The project consists of financing of eligible costs incurred by the government of Morocco in relation to the COVID-19 pandemic. This includes acquisition of medical equipment, medical supplies, drugs and logistics, as well as the strengthening of medical health system with pandemic preparedness interventions.
The project is supporting the National surveillance and response plan to fight COVID-19 of the Moroccan Government. The epidemic of COVID-19 is anticipated to trigger severe shortages in the epidemiological area, healthcare services delivery and supply of critical consumables in an already underfinanced and stretched health sector.
The promoter will implement the project in accordance with the EIB's Environmental and Social principles and standards.
The promoter will implement the project in accordance with the EIB's Guide to Procurement.
This operation is covered by the ELM Guarantee.
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).
News & Stories
General enquiries and comments
The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.
Zero tolerance against fraud and corruption
The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.